ArticleBalkan medical journal2026
Admission-Based Machine-Learning Models for Predicting Mechanical Ventilation and Mortality in Fibrotic Interstitial Lung Disease: A Multicenter Cohort Study with External Validation.
Article in Balkan medical journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Admission-based risk stratification tools are limited for hospitalized patients with fibrotic interstitial lung disease (F-ILD). Aims: To develop and externally validate admission-based machine-learning models for predicting mechanical ventilation (MV), 30-day and 3-month mortality, and long-term all-cause and cause-specific mortality in hospitalized patients with F-ILD. Study Design: Multicenter retrospective cohort study. Methods: This study included hospitalized adults with F-ILD from two tertiary hospitals in China. Clinical characteristics and laboratory test results obtained within 24 hours of admission were used as candidate predictors. Machine-learning models were developed to predict MV, 30-day and 3-month mortality, and long-term all-cause and cause-specific mortality, with internal testing and independent external validation. Model performance, clinical utility, and interpretability were evaluated. Results: A total of 1,272 patients were included (derivation cohort, n = 1,006; external validation cohort, n = 266). In the external validation cohort, the models demonstrated robust discrimination for MV [area under the curve (AUC), 0.913], 30-day mortality (AUC, 0.926), and 3-month mortality (AUC, 0.813). For long-term all-cause mortality, the final model achieved a C-index of 0.768, with time-dependent AUCs of 0.811 at 12 months and 0.768 at 24 months. The corresponding values for cause-specific mortality were 0.768, 0.815, and 0.761, respectively. Lactate dehydrogenase (LDH), neutrophil-to-lymphocyte ratio (NLR), and prognostic nutritional index (PNI) emerged as key predictors of MV and short-term mortality, whereas long-term mortality risk was additionally associated with older age, male sex, smoking history, an idiopathic pulmonary fibrosis phenotype, and lower albumin-to-globulin ratio and platelet-to-white blood cell ratio. Conclusion: Admission-based models demonstrated strong discriminatory performance for predicting MV and mortality in hospitalized patients with F-ILD. Elevated LDH and NLR levels, together with lower PNI, characterized a high-risk profile for acute deterioration and death. Local recalibration may be necessary before implementation in new clinical settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.